Noticias de LLY

Noticias del mercado

Últimas noticias sobre LLY — 531 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: LLY ✕ 531 resultados
01/04/2026 LLY_US — Reuters
Lilly's weight-loss pill wins US approval, sets up next battle with rival Novo Nordisk
01/04/2026 LLY_US — CNBC
FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market
31/03/2026 LLY_US — investor.lilly.com
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders | Eli Lilly and Company
31/03/2026 LLY_US — PR Newswire
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
31/03/2026 LLY_US — The New York Times
Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
30/03/2026 LLY_US — MSN ES ← EN
Jefferies sigue comprando Eli Lilly and Company (LLY)
30/03/2026 LLY_US — Yahoo Finance
Eli Lilly’s (LLY) Shares Up Since Jim Cramer Said He Was a Long Term Believer
30/03/2026 LLY_US — Reuters ES ← EN
Eli Lilly amplía su asociación con Insilico Medicine para el descubrimiento de fármacos impulsado por IA
29/03/2026 LLY_US — Insilico Medicine
Insilico Medicine Announces Global R&D Collaboration with Lilly
29/03/2026 LLY_US — Yahoo Finance
Jefferies Remains a Buy on Eli Lilly and Company (LLY)
28/03/2026 LLY_US — investor.lilly.com
Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity | Eli Lilly and Company
27/03/2026 LLY_US — investor.lilly.com ES ← EN
EBGLYSS (lebrikizumab-lbkz) de Lilly proporcionó hasta cuatro años de control duradero de la enfermedad en pacientes con dermatitis atópica de moderada a grave | Eli Lilly y compañía
25/03/2026 LLY_US — Healthcare Digital
What is in Eli Lilly & Company’s 2025 Year in Review Report?
25/03/2026 LLY_US — Yahoo Finance
Is Eli Lilly (LLY) The Best Healthcare Stock to Buy According to Jim Cramer?
22/03/2026 LLY_US — Yahoo Finance
Eli Lilly and Company (LLY) Expands Zepbound Access as Pricing Reforms Boost Long-Term Growth Outlook
19/03/2026 LLY_US — investor.lilly.com
Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes
19/03/2026 LLY_US — Reuters
Lilly's next-gen drug shows significant blood sugar, weight reduction in diabetes trial
18/03/2026 LLY_US — Yahoo Finance
Eli Lilly and Company (LLY) Gets Downgraded to Reduce From Hold by HSBC – Here’s Why
16/03/2026 LLY_US — Yahoo Finance
Wall Street Firms Turn Bullish on Eli Lilly and Company (LLY) Buoyed by GLP-1 Medication Expansion Plans
15/03/2026 LLY_US — Yahoo Finance
Is Eli Lilly and Company (LLY) A Good Stock To Buy Now?

Página 26 de 27

keyboard_arrow_up